Balyasny Asset Management »

Acumen Pharmaceuticals shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Acumen Pharmaceuticals (ABOS) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Acumen Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acumen Pharmaceuticals held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acumen Pharmaceuticals by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $259k 64k 4.05
2023-12-31 $79k 21k 3.84
2023-06-30 $145k 30k 4.81

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Apple (AAPL)
Select Sector Spdr Tr Financial (XLF)
Pioneer Natural Resources Put Option (PXD)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
JPMorgan Chase & Co. Call Option (JPM)
Hess Call Option (HES)
Ishares Tr Core S&p Mcp Etf (IJH)
Broadcom Call Option (AVGO)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Asml Holding N V N Y Registry Shs Call Option (ASML)

View all positions for Balyasny Asset Management

Top funds holding Acumen Pharmaceuticals

RA Capital Management
Sands Capital Ventures
Franklin Resources
Millennium Management
Rock Springs Capital Management
FMR
Laurion Capital Management
Vanguard Group
T. Rowe Price Associates
Alyeska Investment Group
Jane Street
Susquehanna International
Parkman Healthcare Partners
Hudson Bay Capital Management
Pathstone Holdings

View all funds holding Acumen Pharmaceuticals